Cargando…

Medicine Shortages: Gaps Between Countries and Global Perspectives

Introduction: Over the last decade, global health policies and different research areas have focused on the relevance and impact of medicine shortages. Published studies suggest there have been difficulties with access to medicines since the beginning of the 20th century, and there have been advance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acosta, Angela, Vanegas, Egdda Patricia, Rovira, Joan, Godman, Brian, Bochenek, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658884/ https://www.ncbi.nlm.nih.gov/pubmed/31379565 http://dx.doi.org/10.3389/fphar.2019.00763

Ejemplares similares

Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications
por: Miljković, Nenad, et al.
Publicado: (2020)

Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages
por: Miljković, Nenad, et al.
Publicado: (2020)

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries
por: Bochenek, Tomasz, et al.
Publicado: (2018)

Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications
por: Kwon, Hye-Young, et al.
Publicado: (2018)

Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
por: Pisana, Alice, et al.
Publicado: (2022)

Drug Shortages From the Perspectives of Authorities and Pharmacy Practice in the Netherlands: An Observational Study
por: Postma, Doerine J., et al.
Publicado: (2018)

Medicine shortages: Product life cycle phases and characteristics of medicines in short supply—A register study
por: Sarnola, Kati, et al.
Publicado: (2022)

A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges
por: Vella Bonanno, Patricia, et al.
Publicado: (2021)

Drug Shortage: Causes, Impact, and Mitigation Strategies
por: Shukar, Sundus, et al.
Publicado: (2021)

Traditional medicines and globalization: current and future perspectives in ethnopharmacology
por: Leonti, Marco, et al.
Publicado: (2013)

Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications
por: Modisakeng, Cynthia, et al.
Publicado: (2020)

Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals
por: Miljković, Nenad, et al.
Publicado: (2020)

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
por: Gad, Mohamed, et al.
Publicado: (2020)

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
por: Kim, Yujeong, et al.
Publicado: (2020)

Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP
por: Johnson, Todd A., et al.
Publicado: (2019)

Enhancing Choices Regarding the Administration of Insulin Among Patients With Diabetes Requiring Insulin Across Countries and Implications for Future Care
por: Mardare, Ileana, et al.
Publicado: (2022)

Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries
por: Mahmoud, Mansour Adam, et al.
Publicado: (2023)

Editorial: Emerging Markets’ Health and Pharmaceutical Sectors at the Dawn of a Potential Global Financial Crisis of early 2020s
por: Jakovljevic, Mihajlo, et al.
Publicado: (2022)

Toward a European definition for a drug shortage: a qualitative study
por: De Weerdt, Elfi, et al.
Publicado: (2015)

A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives
por: Bogaert, Petronille, et al.
Publicado: (2015)

Ghana’s herbal medicine industry: prospects, challenges and ways forward from a developing country perspective
por: Asase, Alex
Publicado: (2023)

Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care
por: Kivoto, Patrick M., et al.
Publicado: (2018)

Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study
por: Meyer, Johanna C., et al.
Publicado: (2017)

Health Promotion Development in the Spa Treatment. Perspectives for the European Countries Learned from Poland's Experiences
por: Woźniak-Holecka, Joanna, et al.
Publicado: (2017)

Editorial: Pharmaceutical policy, impact and health outcomes
por: Kwon, Hye-Young, et al.
Publicado: (2023)

Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project
por: Barbieri, Elisa, et al.
Publicado: (2023)

Physician shortage and the future of medicine
por: Hunnicutt, Mary-Kate
Publicado: (2014)

Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe
por: Robertson, Jane, et al.
Publicado: (2021)

Global resource shortages during COVID-19: Bad news for low-income countries
por: McMahon, Devon E., et al.
Publicado: (2020)

A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland
por: Sarnola, Kati, et al.
Publicado: (2019)

Corrigendum: Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications From ESAC-Net and WHO Europe
por: Robertson, Jane, et al.
Publicado: (2021)

Global shortage of personal protective equipment
por: Burki, Talha
Publicado: (2020)

Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications
por: Sefah, Israel Abebrese, et al.
Publicado: (2021)

Tibetan Medicine for Diabetes Mellitus: Overview of Pharmacological Perspectives
por: Yan, Li-Shan, et al.
Publicado: (2021)

Medicine Shortages in Serbia: Pharmacists’ Standpoint and Potential Solutions for a Non-EU Country
por: Jovanović Lješković, Nataša, et al.
Publicado: (2021)

Funding and Service Organization to Achieve Universal Health Coverage for Medicines: An Economic Evaluation of the Best Investment and Service Organization for the Brazilian Scenario.
por: Garcia, Marina Morgado, et al.
Publicado: (2020)

Covid-19 and the N95 respirator shortage: Closing the gap
por: Nogee, Daniel, et al.
Publicado: (2020)

Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications
por: Haque, Mainul, et al.
Publicado: (2021)

Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up
por: Kalinić, Dragan, et al.
Publicado: (2022)

Growth of Global Health Spending Share in Low and Middle Income Countries
por: Jakovljevic, Mihajlo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k5359ll29jcdf4710i0vsr7on9